guardant360 platform (Guardant Health)
86
Structured Review
Guardant Health
guardant360 platform
Guardant360 Platform, supplied by Guardant Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/guardant360+platform/cdx+guardant360/pmc13068569-50-6-9
Average 86 stars, based on 1 article reviews
Guardant360 Platform, supplied by Guardant Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/guardant360+platform/cdx+guardant360/pmc13068569-50-6-9
Average 86 stars, based on 1 article reviews
guardant360 platform - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy. Article Snippet: Patients now receive Article Title: Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy Article Snippet: Patients now receive Next-Generation Sequencing:Article Title: Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy Article Snippet: PURPOSE Advanced esophageal squamous cell carcinoma (ESCC) has a poor prognosis, and current treatments provide limited survival benefits.. This study aimed to identify prognostic biomarkers and therapeutic targets by genomic profiling of advanced ESCC using circulating tumor DNA (ctDNA).. METHODS The SCRUM-MONSTAR GOZILA study is a nationwide, plasma-based molecular profiling project using Guardant360, involving 31 core cancer institutions in Japan. Article Title: Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy Article Snippet: .. NGS analysis of plasma ctDNA from GOZILA study participants was performed using the Clinical Proteomics:Article Title: Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy Article Snippet: PURPOSE Advanced esophageal squamous cell carcinoma (ESCC) has a poor prognosis, and current treatments provide limited survival benefits.. This study aimed to identify prognostic biomarkers and therapeutic targets by genomic profiling of advanced ESCC using circulating tumor DNA (ctDNA).. METHODS The SCRUM-MONSTAR GOZILA study is a nationwide, plasma-based molecular profiling project using Guardant360, involving 31 core cancer institutions in Japan. Article Title: The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing Article Snippet: Tissue-based testing was completed using in-house and proprietary next-generation DNA and RNA sequencing (Comprehensive Solid Tumor HaloPlex HS , version 2.0; Agilent Technology, Inc). .. Plasma-based molecular sequencing utilized the proprietary Article Title: Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy Article Snippet: .. NGS analysis of plasma ctDNA from GOZILA study participants was performed using the Sequencing:Article Title: The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing Article Snippet: Tissue-based testing was completed using in-house and proprietary next-generation DNA and RNA sequencing (Comprehensive Solid Tumor HaloPlex HS , version 2.0; Agilent Technology, Inc). .. Plasma-based molecular sequencing utilized the proprietary |
